JPS5811865B2 - フツソガンユウニコチンサンアミドユウドウタイノ セイゾウホウ - Google Patents

フツソガンユウニコチンサンアミドユウドウタイノ セイゾウホウ

Info

Publication number
JPS5811865B2
JPS5811865B2 JP50090025A JP9002575A JPS5811865B2 JP S5811865 B2 JPS5811865 B2 JP S5811865B2 JP 50090025 A JP50090025 A JP 50090025A JP 9002575 A JP9002575 A JP 9002575A JP S5811865 B2 JPS5811865 B2 JP S5811865B2
Authority
JP
Japan
Prior art keywords
acid
nicotinic acid
yuudou
futsusogan
sanamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP50090025A
Other languages
English (en)
Japanese (ja)
Other versions
JPS51125086A (en
Inventor
エンリコ・デイアマンチ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of JPS51125086A publication Critical patent/JPS51125086A/ja
Publication of JPS5811865B2 publication Critical patent/JPS5811865B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP50090025A 1974-09-05 1975-07-22 フツソガンユウニコチンサンアミドユウドウタイノ セイゾウホウ Expired JPS5811865B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT52879/74A IT1043918B (it) 1974-09-05 1974-09-05 Ammidi fluorurate dell acido nicotinico e procedimento per loro preparazione

Publications (2)

Publication Number Publication Date
JPS51125086A JPS51125086A (en) 1976-11-01
JPS5811865B2 true JPS5811865B2 (ja) 1983-03-04

Family

ID=11278222

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50090025A Expired JPS5811865B2 (ja) 1974-09-05 1975-07-22 フツソガンユウニコチンサンアミドユウドウタイノ セイゾウホウ

Country Status (7)

Country Link
JP (1) JPS5811865B2 (show.php)
BE (1) BE833115A (show.php)
DE (1) DE2534964A1 (show.php)
FR (1) FR2283680A1 (show.php)
GB (1) GB1483138A (show.php)
IT (1) IT1043918B (show.php)
SE (1) SE416466B (show.php)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4973597A (en) * 1989-06-30 1990-11-27 Eli Lilly And Company Anticonvulsant agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2365265A (en) * 1941-08-30 1944-12-19 Du Pont Insoluble azo dyes
US3462532A (en) * 1967-08-28 1969-08-19 Dow Chemical Co Controlling gastropods with nicotinanilide or alkylaryl nicotinamide gastropodicides

Also Published As

Publication number Publication date
JPS51125086A (en) 1976-11-01
FR2283680B1 (show.php) 1979-08-10
DE2534964A1 (de) 1976-03-25
GB1483138A (en) 1977-08-17
FR2283680A1 (fr) 1976-04-02
SE416466B (sv) 1981-01-05
SE7509692L (sv) 1976-03-08
IT1043918B (it) 1980-02-29
BE833115A (fr) 1975-12-31

Similar Documents

Publication Publication Date Title
US6965036B2 (en) Intermediates for guanidine mimics as factor Xa inhibitors
SU662005A3 (ru) Способ получени замещенных бензамидов или их солей
JPS6318584B2 (show.php)
CN103923001B (zh) 瑞戈非尼盐及其晶型、制备方法
JP2013139476A (ja) Ｎ−ヒドロキシ−３−［４−［［［２−（２−メチル−１ｈ−インドール−３−イル）エチル］アミノ］メチル］フェニル］−２ｅ−２−プロペンアミドの多形
JPH0733729A (ja) Ｎ−シアノ−ｎ′−置換−アリールカルボキシイミダミド化合物の製造法
JPS59118774A (ja) 置換されたフエニルスルホニルオキシベンズイミダゾ−ルカルバメ−トおよびそれらの製造法
KR101050680B1 (ko) 콜라게네이즈의 선택적인 억제를 위한 신규한피리미딘-4,6-디카복스아미드
CN103755644B (zh) 化合物、其合成及用其合成双UPy取代化合物的方法
JPS5811865B2 (ja) フツソガンユウニコチンサンアミドユウドウタイノ セイゾウホウ
JPH0774205B2 (ja) 新規イミダゾ−ル誘導体
CN112574087B (zh) 一种3-氨基吡咯烷盐酸盐的合成方法
US2793212A (en) Substituted benzamidopiperidinopropanes
GB2060619A (en) 4-Aryl-4-Aryloxypiperidines
CN114560862A (zh) 一种吡咯并[1,2-a]喹喔啉-4(5h)-酮及其衍生物的合成方法
US3299070A (en) Piperazine amides of 3-phenylcinnoline-4-carboxylic acids
CN116120261B (zh) 一种3-[（4-磺胺哌嗪-1-基）甲基]苯甲酸类化合物的制备方法
CN114890952B (zh) 一种5-卤代-2-氨基苯并氮杂环类化合物的制备方法
CN100532358C (zh) 氨氯地平的拆分方法
CN110590641B (zh) 一种3-羟基异吲哚-1-酮系列化合物的绿色制备方法
CN120923396A (zh) 一种二氟甲氧基取代的氮杂环衍生物的合成方法
JPS61267542A (ja) アミノベンズアミド化合物
JPS6036423B2 (ja) 新規ヒドラジンの製法
JP2577215B2 (ja) ベンジルイソキノリン誘導体
CN114634471A (zh) 一种合成γ-羟基-γ-全氟甲基环外双键丁内酯类化合物的方法